{"transactions":[{"id":4635914,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":42054,"kind":"person","name":"Kaye Mark","position":1,"cik":"0001748691","reported_name":"Kaye Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & CFO"}}],"security":"Common Stock","published_at":"2026-10-06T20:02:46.000Z","date":"2026-10-02","kind":"grant","planned":false,"acquired":true,"shares":2627,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents performance based restricted share units. Restrictions lapsed on 10/2/2026."}],"balance_after":30503,"source":{"system":"sec-edgar","filing":"0001748691-26-000005","document":"wk-form4_1791316964.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1748691/000174869126000005/wk-form4_1791316964.xml","form_type":"4"}},{"id":4635913,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":42054,"kind":"person","name":"Kaye Mark","position":1,"cik":"0001748691","reported_name":"Kaye Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & CFO"}}],"security":"Common Stock","published_at":"2026-10-06T20:02:46.000Z","date":"2026-10-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":4161,"price":386.43,"value":1607935.23,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK."}],"balance_after":27876,"source":{"system":"sec-edgar","filing":"0001748691-26-000005","document":"wk-form4_1791316964.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1748691/000174869126000005/wk-form4_1791316964.xml","form_type":"4"}},{"id":4376,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":10035,"kind":"person","name":"Wessling Erin M","position":1,"cik":"0002084548","reported_name":"Wessling Erin M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Legal Officer"}}],"security":"Common Stock","published_at":"2026-09-04T20:06:17.000Z","date":"2026-09-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":255,"price":414.78,"value":105768.9,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK."}],"balance_after":7230,"source":{"system":"sec-edgar","filing":"0002084548-26-000005","document":"wk-form4_1788552374.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2084548/000208454826000005/wk-form4_1788552374.xml","form_type":"4"}},{"id":4375,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":10035,"kind":"person","name":"Wessling Erin M","position":1,"cik":"0002084548","reported_name":"Wessling Erin M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Legal Officer"}}],"security":"Common Stock","published_at":"2026-09-04T20:06:17.000Z","date":"2026-09-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":94,"price":405.84,"value":38148.96,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK."}],"balance_after":7485,"source":{"system":"sec-edgar","filing":"0002084548-26-000005","document":"wk-form4_1788552374.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2084548/000208454826000005/wk-form4_1788552374.xml","form_type":"4"}},{"id":4360,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":10030,"kind":"person","name":"Craig Ryan R","position":1,"cik":"0002084547","reported_name":"Craig Ryan R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief HR Officer"}}],"security":"Common Stock","published_at":"2026-09-04T20:05:26.000Z","date":"2026-09-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":144,"price":405.84,"value":58440.96,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK."}],"balance_after":6530,"source":{"system":"sec-edgar","filing":"0002084547-26-000009","document":"wk-form4_1788552323.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2084547/000208454726000009/wk-form4_1788552323.xml","form_type":"4"}},{"id":707194,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":17760,"kind":"person","name":"PERU RAMIRO G","position":1,"cik":"0001192045","reported_name":"PERU RAMIRO G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-07-17T19:04:55.000Z","date":"2026-07-17","kind":"purchase","planned":false,"acquired":true,"shares":1000,"price":366.05,"value":366050.0,"ownership":{"direct":true},"balance_after":10908,"source":{"system":"sec-edgar","filing":"0001192045-26-000004","document":"wk-form4_1784315092.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000119204526000004/wk-form4_1784315092.xml","form_type":"4"}},{"id":707192,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":12574,"kind":"person","name":"BOUDREAUX GAIL","position":1,"cik":"0001287920","reported_name":"BOUDREAUX GAIL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-07-17T17:50:44.000Z","date":"2026-07-17","kind":"purchase","planned":false,"acquired":true,"shares":2045,"price":368.25,"value":753071.25,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple purchases at prices ranging from $367.76 to $368.69. The price reported reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":171976,"source":{"system":"sec-edgar","filing":"0001287920-26-000006","document":"wk-form4_1784310641.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000128792026000006/wk-form4_1784310641.xml","form_type":"4"}},{"id":707191,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":12574,"kind":"person","name":"BOUDREAUX GAIL","position":1,"cik":"0001287920","reported_name":"BOUDREAUX GAIL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-07-17T17:50:44.000Z","date":"2026-07-17","kind":"purchase","planned":false,"acquired":true,"shares":680,"price":366.41,"value":249158.8,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple purchases at prices ranging from $366.14 to $366.48. The price reported reflects the weighted average purchase price. The reporting person hereby\nundertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":169931,"source":{"system":"sec-edgar","filing":"0001287920-26-000006","document":"wk-form4_1784310641.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000128792026000006/wk-form4_1784310641.xml","form_type":"4"}},{"id":738201,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":38289,"kind":"person","name":"Penczek Ronald W","position":1,"cik":"0001659075","reported_name":"Penczek Ronald W","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CAO & Controller"}}],"security":"Common Stock","published_at":"2026-06-15T20:10:45.000Z","date":"2026-06-12","kind":"sale","planned":false,"acquired":false,"shares":369,"price":403.16,"value":148766.04,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $403.15 to $403.31. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":3740,"source":{"system":"sec-edgar","filing":"0001659075-26-000006","document":"wk-form4_1781554242.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000165907526000006/wk-form4_1781554242.xml","form_type":"4"}},{"id":740369,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":36255,"kind":"person","name":"Dixon Robert L JR","position":1,"cik":"0001524849","reported_name":"Dixon Robert L JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-12T20:12:50.000Z","date":"2026-06-11","kind":"sale","planned":false,"acquired":false,"shares":151,"price":401.77,"value":60667.27,"ownership":{"direct":true},"balance_after":10734,"source":{"system":"sec-edgar","filing":"0001524849-26-000004","document":"wk-form4_1781295167.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000152484926000004/wk-form4_1781295167.xml","form_type":"4"}},{"id":770341,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":38289,"kind":"person","name":"Penczek Ronald W","position":1,"cik":"0001659075","reported_name":"Penczek Ronald W","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CAO & Controller"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2026-05-20T20:11:33.000Z","date":"2026-05-19","kind":"exercise","planned":false,"acquired":false,"shares":877,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Fully vested."}],"balance_after":0,"derivative":{"exercise_price":311.48,"expiration_date":"2031-03-01","underlying":"Common Stock","underlying_shares":877},"source":{"system":"sec-edgar","filing":"0001659075-26-000004","document":"wk-form4_1779307888.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000165907526000004/wk-form4_1779307888.xml","form_type":"4"}},{"id":770340,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":38289,"kind":"person","name":"Penczek Ronald W","position":1,"cik":"0001659075","reported_name":"Penczek Ronald W","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CAO & Controller"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2026-05-20T20:11:33.000Z","date":"2026-05-19","kind":"exercise","planned":false,"acquired":false,"shares":654,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Fully vested."}],"balance_after":0,"derivative":{"exercise_price":271.27,"expiration_date":"2030-03-02","underlying":"Common Stock","underlying_shares":654},"source":{"system":"sec-edgar","filing":"0001659075-26-000004","document":"wk-form4_1779307888.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000165907526000004/wk-form4_1779307888.xml","form_type":"4"}},{"id":770339,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":38289,"kind":"person","name":"Penczek Ronald W","position":1,"cik":"0001659075","reported_name":"Penczek Ronald W","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CAO & Controller"}}],"security":"Common Stock","published_at":"2026-05-20T20:11:33.000Z","date":"2026-05-19","kind":"sale","planned":false,"acquired":false,"shares":1531,"price":403.13,"value":617192.03,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades, each at the same price of $403.13."}],"balance_after":4109,"source":{"system":"sec-edgar","filing":"0001659075-26-000004","document":"wk-form4_1779307888.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000165907526000004/wk-form4_1779307888.xml","form_type":"4"}},{"id":770338,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":38289,"kind":"person","name":"Penczek Ronald W","position":1,"cik":"0001659075","reported_name":"Penczek Ronald W","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CAO & Controller"}}],"security":"Common Stock","published_at":"2026-05-20T20:11:33.000Z","date":"2026-05-19","kind":"exercise","planned":false,"acquired":true,"shares":877,"price":311.48,"value":273167.96,"ownership":{"direct":true},"balance_after":5640,"source":{"system":"sec-edgar","filing":"0001659075-26-000004","document":"wk-form4_1779307888.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000165907526000004/wk-form4_1779307888.xml","form_type":"4"}},{"id":770337,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":38289,"kind":"person","name":"Penczek Ronald W","position":1,"cik":"0001659075","reported_name":"Penczek Ronald W","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CAO & Controller"}}],"security":"Common Stock","published_at":"2026-05-20T20:11:33.000Z","date":"2026-05-19","kind":"exercise","planned":false,"acquired":true,"shares":654,"price":271.27,"value":177410.58,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Balance includes 10.21 shares acquired on March 25, 2026 through a dividend reinvestment plan."}],"balance_after":4763,"source":{"system":"sec-edgar","filing":"0001659075-26-000004","document":"wk-form4_1779307888.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000165907526000004/wk-form4_1779307888.xml","form_type":"4"}},{"id":777523,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":34539,"kind":"person","name":"STRABLE-SOETHOUT DEANNA D","position":1,"cik":"0001278726","reported_name":"STRABLE-SOETHOUT DEANNA D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-15T20:33:51.000Z","date":"2026-05-13","kind":"grant","planned":false,"acquired":true,"shares":563,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Deferred stock units accrued under the Elevance Health, Inc. (\"Company\") Board of Directors Compensation Program."},{"field":"shares","element":"transactionShares","label":"F2","text":"The deferred stock units shall be payable in Company common stock upon the first to occur of (a) five years from the date of grant or (b) the date the Reporting Person ceases to be a member of the Company's board of directors, unless a later date is designated in the Reporting Person's election made under the Company's Board of Directors Deferred Compensation Plan."}],"balance_after":2209,"source":{"system":"sec-edgar","filing":"0001628280-26-035643","document":"wk-form4_1778877227.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000162828026035643/wk-form4_1778877227.xml","form_type":"4"}},{"id":777522,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":16563,"kind":"person","name":"SCHULMAN AMY W","position":1,"cik":"0001438226","reported_name":"SCHULMAN AMY W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-15T20:16:22.000Z","date":"2026-05-13","kind":"grant","planned":false,"acquired":true,"shares":563,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Deferred stock units accrued under the Elevance Health, Inc. (\"Company\") Board of Directors Compensation Program."},{"field":"shares","element":"transactionShares","label":"F2","text":"The deferred stock units shall be payable in Company common stock upon the first to occur of (a) five years from the date of grant or (b) the date the Reporting Person ceases to be a member of the Company's board of directors, unless a later date is designated in the Reporting Person's election made under the Company's Board of Directors Deferred Compensation Plan."}],"balance_after":781,"source":{"system":"sec-edgar","filing":"0001438226-26-000009","document":"wk-form4_1778876180.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000143822626000009/wk-form4_1778876180.xml","form_type":"4"}},{"id":777521,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":16329,"kind":"person","name":"Schneider Ryan M.","position":1,"cik":"0001420501","reported_name":"Schneider Ryan M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-15T20:15:47.000Z","date":"2026-05-13","kind":"grant","planned":false,"acquired":true,"shares":563,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Deferred stock units accrued under the Elevance Health, Inc. (\"Company\") Board of Directors Compensation Program."},{"field":"shares","element":"transactionShares","label":"F2","text":"The deferred stock units shall be payable in Company common stock upon the first to occur of (a) five years from the date of grant or (b) the date the Reporting Person ceases to be a member of the Company's board of directors, unless a later date is designated in the Reporting Person's election made under the Company's Board of Directors Deferred Compensation Plan."}],"balance_after":7163,"source":{"system":"sec-edgar","filing":"0001420501-26-000004","document":"wk-form4_1778876145.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000142050126000004/wk-form4_1778876145.xml","form_type":"4"}},{"id":777520,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":17760,"kind":"person","name":"PERU RAMIRO G","position":1,"cik":"0001192045","reported_name":"PERU RAMIRO G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-15T20:15:18.000Z","date":"2026-05-13","kind":"grant","planned":false,"acquired":true,"shares":563,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Deferred stock units accrued under the Elevance Health, Inc. (\"Company\") Board of Directors Compensation Program."},{"field":"shares","element":"transactionShares","label":"F2","text":"The deferred stock units shall be payable in Company common stock upon the first to occur of (a) five years from the date of grant or (b) the date the Reporting Person ceases to be a member of the Company's board of directors, unless a later date is designated in the Reporting Person's election made under the Company's Board of Directors Deferred Compensation Plan."}],"balance_after":9908,"source":{"system":"sec-edgar","filing":"0001192045-26-000002","document":"wk-form4_1778876111.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000119204526000002/wk-form4_1778876111.xml","form_type":"4"}},{"id":777519,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":47000,"kind":"person","name":"Neri Antonio F","position":1,"cik":"0001648401","reported_name":"Neri Antonio F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-15T20:14:44.000Z","date":"2026-05-13","kind":"grant","planned":false,"acquired":true,"shares":563,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Deferred stock units accrued under the Elevance Health, Inc. (\"Company\") Board of Directors Compensation Program."},{"field":"shares","element":"transactionShares","label":"F2","text":"The deferred stock units shall be payable in Company common stock upon the first to occur of (a) five years from the date of grant or (b) the date the Reporting Person ceases to be a member of the Company's board of directors, unless a later date is designated in the Reporting Person's election made under the Company's Board of Directors Deferred Compensation Plan."}],"balance_after":5488,"source":{"system":"sec-edgar","filing":"0001648401-26-000006","document":"wk-form4_1778876082.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000164840126000006/wk-form4_1778876082.xml","form_type":"4"}},{"id":777518,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":46999,"kind":"person","name":"Jallal Bahija","position":1,"cik":"0001730038","reported_name":"Jallal Bahija","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-15T20:14:01.000Z","date":"2026-05-13","kind":"grant","planned":false,"acquired":true,"shares":563,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Deferred stock units accrued under the Elevance Health, Inc. (\"Company\") Board of Directors Compensation Program."},{"field":"shares","element":"transactionShares","label":"F2","text":"The deferred stock units shall be payable in Company common stock upon the first to occur of (a) five years from the date of grant or (b) the date the Reporting Person ceases to be a member of the Company's board of directors, unless a later date is designated in the Reporting Person's election made under the Company's Board of Directors Deferred Compensation Plan."}],"balance_after":5351,"source":{"system":"sec-edgar","filing":"0001730038-26-000004","document":"wk-form4_1778876036.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000173003826000004/wk-form4_1778876036.xml","form_type":"4"}},{"id":777517,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":16069,"kind":"person","name":"HAY LEWIS III","position":1,"cik":"0001182705","reported_name":"HAY LEWIS III","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-15T20:12:42.000Z","date":"2026-05-13","kind":"grant","planned":false,"acquired":true,"shares":563,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Deferred stock units accrued under the Elevance Health, Inc. (\"Company\") Board of Directors Compensation Program."},{"field":"shares","element":"transactionShares","label":"F2","text":"The deferred stock units shall be payable in Company common stock upon the first to occur of (a) five years from the date of grant or (b) the date the Reporting Person ceases to be a member of the Company's board of directors, unless a later date is designated in the Reporting Person's election made under the Company's Board of Directors Deferred Compensation Plan."}],"balance_after":12070,"source":{"system":"sec-edgar","filing":"0001182705-26-000004","document":"wk-form4_1778875959.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000118270526000004/wk-form4_1778875959.xml","form_type":"4"}},{"id":777516,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":36255,"kind":"person","name":"Dixon Robert L JR","position":1,"cik":"0001524849","reported_name":"Dixon Robert L JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-15T20:12:15.000Z","date":"2026-05-13","kind":"grant","planned":false,"acquired":true,"shares":563,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Deferred stock units accrued under the Elevance Health, Inc. (\"Company\") Board of Directors Compensation Program."},{"field":"shares","element":"transactionShares","label":"F2","text":"The deferred stock units shall be payable in Company common stock upon the first to occur of (a) five years from the date of grant or (b) the date the Reporting Person ceases to be a member of the Company's board of directors, unless a later date is designated in the Reporting Person's election made under the Company's Board of Directors Deferred Compensation Plan."}],"balance_after":10885,"source":{"system":"sec-edgar","filing":"0001524849-26-000002","document":"wk-form4_1778875932.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000152484926000002/wk-form4_1778875932.xml","form_type":"4"}},{"id":777515,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":43706,"kind":"person","name":"DeVore Susan D.","position":1,"cik":"0001587697","reported_name":"DeVore Susan D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-15T20:11:33.000Z","date":"2026-05-13","kind":"grant","planned":false,"acquired":true,"shares":563,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Deferred stock units accrued under the Elevance Health, Inc. (\"Company\") Board of Directors Compensation Program."},{"field":"shares","element":"transactionShares","label":"F2","text":"The deferred stock units shall be payable in Company common stock upon the first to occur of (a) five years from the date of grant or (b) the date the Reporting Person ceases to be a member of the Company's board of directors, unless a later date is designated in the Reporting Person's election made under the Company's Board of Directors Deferred Compensation Plan."}],"balance_after":4065,"source":{"system":"sec-edgar","filing":"0001587697-26-000006","document":"wk-form4_1778875890.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000158769726000006/wk-form4_1778875890.xml","form_type":"4"}},{"id":777512,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":43542,"kind":"person","name":"COLLIS STEVEN H","position":1,"cik":"0001191508","reported_name":"COLLIS STEVEN H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-15T20:10:47.000Z","date":"2026-05-13","kind":"grant","planned":false,"acquired":true,"shares":563,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Deferred stock units accrued under the Elevance Health, Inc. (\"Company\") Board of Directors Compensation Program."},{"field":"shares","element":"transactionShares","label":"F2","text":"The deferred stock units shall be payable in Company common stock upon the first to occur of (a) five years from the date of grant or (b) the date the Reporting Person ceases to be a member of the Company's board of directors, unless a later date is designated in the Reporting Person's election made under the Company's Board of Directors Deferred Compensation Plan."}],"balance_after":4202,"source":{"system":"sec-edgar","filing":"0001191508-26-000004","document":"wk-form4_1778875844.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000119150826000004/wk-form4_1778875844.xml","form_type":"4"}},{"id":831112,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":16563,"kind":"person","name":"SCHULMAN AMY W","position":1,"cik":"0001438226","reported_name":"SCHULMAN AMY W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-03-23T20:10:37.000Z","date":"2026-03-12","kind":"sale","planned":false,"acquired":false,"shares":26,"price":287.5,"value":7475.0,"ownership":{"direct":true},"balance_after":218,"source":{"system":"sec-edgar","filing":"0001438226-26-000007","document":"wk-form4_1774296634.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000143822626000007/wk-form4_1774296634.xml","form_type":"4"}},{"id":854044,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":62080,"kind":"person","name":"Kendrick Charles Morgan JR","position":1,"cik":"0001887908","reported_name":"Kendrick Charles Morgan JR","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & President, Commercial"}}],"security":"Common Stock","published_at":"2026-03-09T20:45:08.000Z","date":"2026-03-06","kind":"sale","planned":false,"acquired":false,"shares":3196,"price":284.92,"value":910604.32,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $284.82 to $285.08. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":11791,"source":{"system":"sec-edgar","filing":"0001887908-26-000005","document":"wk-form4_1773089106.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000188790826000005/wk-form4_1773089106.xml","form_type":"4"}},{"id":856471,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":43542,"kind":"person","name":"COLLIS STEVEN H","position":1,"cik":"0001191508","reported_name":"COLLIS STEVEN H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-03-06T13:03:27.000Z","date":"2026-03-05","kind":"purchase","planned":false,"acquired":true,"shares":3000,"price":289.84,"value":869520.0,"ownership":{"direct":true},"balance_after":3639,"source":{"system":"sec-edgar","filing":"0001191508-26-000002","document":"wk-form4_1772802204.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000119150826000002/wk-form4_1772802204.xml","form_type":"4"}},{"id":862580,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":38289,"kind":"person","name":"Penczek Ronald W","position":1,"cik":"0001659075","reported_name":"Penczek Ronald W","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CAO & Controller"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2026-03-04T22:00:06.000Z","date":"2026-03-02","kind":"grant","planned":false,"acquired":true,"shares":1677,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The option represents a right to purchase a total of 1,677 shares, and is exercisable in three annual installments, each installment of 559 shares, beginning on 3/2/2027, which is the one-year anniversary of the option grant date."}],"balance_after":1677,"derivative":{"exercise_price":294.07,"expiration_date":"2036-03-02","underlying":"Common Stock","underlying_shares":1677},"source":{"system":"sec-edgar","filing":"0001659075-26-000002","document":"wk-form4_1772661603.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000165907526000002/wk-form4_1772661603.xml","form_type":"4"}},{"id":862579,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":38289,"kind":"person","name":"Penczek Ronald W","position":1,"cik":"0001659075","reported_name":"Penczek Ronald W","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CAO & Controller"}}],"security":"Common Stock","published_at":"2026-03-04T22:00:06.000Z","date":"2026-03-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":37,"price":284.03,"value":10509.11,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK."}],"balance_after":4099,"source":{"system":"sec-edgar","filing":"0001659075-26-000002","document":"wk-form4_1772661603.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000165907526000002/wk-form4_1772661603.xml","form_type":"4"}},{"id":862578,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":38289,"kind":"person","name":"Penczek Ronald W","position":1,"cik":"0001659075","reported_name":"Penczek Ronald W","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CAO & Controller"}}],"security":"Common Stock","published_at":"2026-03-04T22:00:06.000Z","date":"2026-03-02","kind":"grant","planned":false,"acquired":true,"shares":266,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F5","text":"Represents performance based restricted share units. Restrictions lapsed on 3/2/2026."}],"balance_after":4136,"source":{"system":"sec-edgar","filing":"0001659075-26-000002","document":"wk-form4_1772661603.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000165907526000002/wk-form4_1772661603.xml","form_type":"4"}},{"id":862577,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":38289,"kind":"person","name":"Penczek Ronald W","position":1,"cik":"0001659075","reported_name":"Penczek Ronald W","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CAO & Controller"}}],"security":"Common Stock","published_at":"2026-03-04T22:00:06.000Z","date":"2026-03-02","kind":"grant","planned":false,"acquired":true,"shares":1701,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Represents restricted share units. Restrictions lapse as follows: 850 shares on 3/2/2027, and 851 shares on 3/2/2028."}],"balance_after":3870,"source":{"system":"sec-edgar","filing":"0001659075-26-000002","document":"wk-form4_1772661603.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000165907526000002/wk-form4_1772661603.xml","form_type":"4"}},{"id":862576,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":38289,"kind":"person","name":"Penczek Ronald W","position":1,"cik":"0001659075","reported_name":"Penczek Ronald W","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CAO & Controller"}}],"security":"Common Stock","published_at":"2026-03-04T22:00:06.000Z","date":"2026-03-02","kind":"grant","planned":false,"acquired":true,"shares":426,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents restricted share units. Restrictions lapse as follows: 142 shares on 3/2/2027, 3/2/2028 and 3/2/2029."}],"balance_after":2169,"source":{"system":"sec-edgar","filing":"0001659075-26-000002","document":"wk-form4_1772661603.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000165907526000002/wk-form4_1772661603.xml","form_type":"4"}},{"id":862575,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":38289,"kind":"person","name":"Penczek Ronald W","position":1,"cik":"0001659075","reported_name":"Penczek Ronald W","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CAO & Controller"}}],"security":"Common Stock","published_at":"2026-03-04T22:00:06.000Z","date":"2026-03-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":131,"price":294.07,"value":38523.17,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Balance includes 7.06 shares acquired on March 25, 2025, 6.14 shares acquired on June 25, 2025, 7.18 shares acquired on September 25, 2025 and 6.85 shares acquired on December 19, 2025 through a dividend reinvestment plan."}],"balance_after":1743,"source":{"system":"sec-edgar","filing":"0001659075-26-000002","document":"wk-form4_1772661603.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000165907526000002/wk-form4_1772661603.xml","form_type":"4"}},{"id":862574,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":10035,"kind":"person","name":"Wessling Erin M","position":1,"cik":"0002084548","reported_name":"Wessling Erin M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Legal Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2026-03-04T21:59:45.000Z","date":"2026-03-02","kind":"grant","planned":false,"acquired":true,"shares":11754,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option represents a right to purchase a total of 11,754 shares, and is exercisable in three annual installments, each installment of 3,918 shares, beginning on 3/2/2027, which is the one-year anniversary of the option grant date."}],"balance_after":11754,"derivative":{"exercise_price":294.07,"expiration_date":"2036-03-02","underlying":"Common Stock","underlying_shares":11754},"source":{"system":"sec-edgar","filing":"0002084548-26-000002","document":"wk-form4_1772661583.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000208454826000002/wk-form4_1772661583.xml","form_type":"4"}},{"id":862573,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":10035,"kind":"person","name":"Wessling Erin M","position":1,"cik":"0002084548","reported_name":"Wessling Erin M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Legal Officer"}}],"security":"Common Stock","published_at":"2026-03-04T21:59:45.000Z","date":"2026-03-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":417,"price":284.03,"value":118440.51,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK."}],"balance_after":7579,"source":{"system":"sec-edgar","filing":"0002084548-26-000002","document":"wk-form4_1772661583.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000208454826000002/wk-form4_1772661583.xml","form_type":"4"}},{"id":862572,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":10035,"kind":"person","name":"Wessling Erin M","position":1,"cik":"0002084548","reported_name":"Wessling Erin M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Legal Officer"}}],"security":"Common Stock","published_at":"2026-03-04T21:59:45.000Z","date":"2026-03-02","kind":"grant","planned":false,"acquired":true,"shares":2976,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted share units. Restrictions lapse as follows: 992 shares on 3/2/2027, 3/2/2028 and 3/2/2029."}],"balance_after":7996,"source":{"system":"sec-edgar","filing":"0002084548-26-000002","document":"wk-form4_1772661583.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000208454826000002/wk-form4_1772661583.xml","form_type":"4"}},{"id":862571,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":10030,"kind":"person","name":"Craig Ryan R","position":1,"cik":"0002084547","reported_name":"Craig Ryan R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief HR Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2026-03-04T21:59:14.000Z","date":"2026-03-02","kind":"grant","planned":false,"acquired":true,"shares":11754,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The option represents a right to purchase a total of 11,754 shares, and is exercisable in three annual installments, each installment of 3,918 shares, beginning on 3/2/2027, which is the one-year anniversary of the option grant date."}],"balance_after":11754,"derivative":{"exercise_price":294.07,"exercise_date":"2036-03-02","underlying":"Common Stock","underlying_shares":11754},"source":{"system":"sec-edgar","filing":"0002084547-26-000005","document":"wk-form4_1772661549.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000208454726000005/wk-form4_1772661549.xml","form_type":"4"}},{"id":862570,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":10030,"kind":"person","name":"Craig Ryan R","position":1,"cik":"0002084547","reported_name":"Craig Ryan R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief HR Officer"}}],"security":"Common Stock","published_at":"2026-03-04T21:59:14.000Z","date":"2026-03-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":309,"price":284.03,"value":87765.27,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK."}],"balance_after":6674,"source":{"system":"sec-edgar","filing":"0002084547-26-000005","document":"wk-form4_1772661549.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000208454726000005/wk-form4_1772661549.xml","form_type":"4"}},{"id":862569,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":10030,"kind":"person","name":"Craig Ryan R","position":1,"cik":"0002084547","reported_name":"Craig Ryan R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief HR Officer"}}],"security":"Common Stock","published_at":"2026-03-04T21:59:14.000Z","date":"2026-03-02","kind":"grant","planned":false,"acquired":true,"shares":2976,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents restricted share units. Restrictions lapse as follows: 992 shares on 3/2/2027, 3/2/2028 and 3/2/2029."}],"balance_after":6983,"source":{"system":"sec-edgar","filing":"0002084547-26-000005","document":"wk-form4_1772661549.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000208454726000005/wk-form4_1772661549.xml","form_type":"4"}},{"id":862568,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":10030,"kind":"person","name":"Craig Ryan R","position":1,"cik":"0002084547","reported_name":"Craig Ryan R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief HR Officer"}}],"security":"Common Stock","published_at":"2026-03-04T21:59:14.000Z","date":"2026-03-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":25,"price":294.07,"value":7351.75,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK."}],"balance_after":4007,"source":{"system":"sec-edgar","filing":"0002084547-26-000005","document":"wk-form4_1772661549.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000208454726000005/wk-form4_1772661549.xml","form_type":"4"}},{"id":862567,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":10909,"kind":"person","name":"Norwood Felicia F","position":1,"cik":"0001743548","reported_name":"Norwood Felicia F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP &Chief Health Benefits Ofr"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2026-03-04T21:58:49.000Z","date":"2026-03-02","kind":"grant","planned":false,"acquired":true,"shares":23512,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option represents a right to purchase a total of 23,512 shares, and is exercisable in two installments of 7,837 shares each and one installment of 7,838 shares, beginning on 3/2/2027, which is the one-year anniversary of the option grant date."}],"balance_after":23512,"derivative":{"exercise_price":294.07,"expiration_date":"2036-03-02","underlying":"Common Stock","underlying_shares":23512},"source":{"system":"sec-edgar","filing":"0001743548-26-000002","document":"wk-form4_1772661524.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000174354826000002/wk-form4_1772661524.xml","form_type":"4"}},{"id":862566,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":10909,"kind":"person","name":"Norwood Felicia F","position":1,"cik":"0001743548","reported_name":"Norwood Felicia F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP &Chief Health Benefits Ofr"}}],"security":"Common Stock","published_at":"2026-03-04T21:58:49.000Z","date":"2026-03-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":496,"price":284.03,"value":140878.88,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK."}],"balance_after":38838,"source":{"system":"sec-edgar","filing":"0001743548-26-000002","document":"wk-form4_1772661524.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000174354826000002/wk-form4_1772661524.xml","form_type":"4"}},{"id":862565,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":10909,"kind":"person","name":"Norwood Felicia F","position":1,"cik":"0001743548","reported_name":"Norwood Felicia F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP &Chief Health Benefits Ofr"}}],"security":"Common Stock","published_at":"2026-03-04T21:58:49.000Z","date":"2026-03-02","kind":"grant","planned":false,"acquired":true,"shares":2865,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents performance based restricted share units. Restrictions lapsed on 3/2/2026."}],"balance_after":39334,"source":{"system":"sec-edgar","filing":"0001743548-26-000002","document":"wk-form4_1772661524.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000174354826000002/wk-form4_1772661524.xml","form_type":"4"}},{"id":862564,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":10909,"kind":"person","name":"Norwood Felicia F","position":1,"cik":"0001743548","reported_name":"Norwood Felicia F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP &Chief Health Benefits Ofr"}}],"security":"Common Stock","published_at":"2026-03-04T21:58:49.000Z","date":"2026-03-02","kind":"grant","planned":false,"acquired":true,"shares":5951,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents restricted share units. Restrictions lapse as follows: 1,983 shares on 3/2/2027, and 1,984 shares each on 3/2/2028 and 3/2/2029."}],"balance_after":36469,"source":{"system":"sec-edgar","filing":"0001743548-26-000002","document":"wk-form4_1772661524.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000174354826000002/wk-form4_1772661524.xml","form_type":"4"}},{"id":862563,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":10909,"kind":"person","name":"Norwood Felicia F","position":1,"cik":"0001743548","reported_name":"Norwood Felicia F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP &Chief Health Benefits Ofr"}}],"security":"Common Stock","published_at":"2026-03-04T21:58:49.000Z","date":"2026-03-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":1421,"price":294.07,"value":417873.47,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK."}],"balance_after":30518,"source":{"system":"sec-edgar","filing":"0001743548-26-000002","document":"wk-form4_1772661524.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000174354826000002/wk-form4_1772661524.xml","form_type":"4"}},{"id":862562,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":62915,"kind":"person","name":"LAVU RATNAKAR","position":1,"cik":"0001737620","reported_name":"LAVU RATNAKAR","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Digital Info Ofr"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2026-03-04T21:58:27.000Z","date":"2026-03-02","kind":"grant","planned":false,"acquired":true,"shares":20152,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option represents a right to purchase a total of 20,152 shares, and is exercisable in two installments of 6,717 shares each and one installment of 6,718 shares, beginning on 3/2/2027, which is the one-year anniversary of the option grant date."}],"balance_after":20152,"derivative":{"exercise_price":294.07,"expiration_date":"2036-03-02","underlying":"Common Stock","underlying_shares":20152},"source":{"system":"sec-edgar","filing":"0001737620-26-000002","document":"wk-form4_1772661505.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000173762026000002/wk-form4_1772661505.xml","form_type":"4"}},{"id":862561,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":62915,"kind":"person","name":"LAVU RATNAKAR","position":1,"cik":"0001737620","reported_name":"LAVU RATNAKAR","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Digital Info Ofr"}}],"security":"Common Stock","published_at":"2026-03-04T21:58:27.000Z","date":"2026-03-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":222,"price":284.03,"value":63054.66,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK."}],"balance_after":16149,"source":{"system":"sec-edgar","filing":"0001737620-26-000002","document":"wk-form4_1772661505.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000173762026000002/wk-form4_1772661505.xml","form_type":"4"}},{"id":862560,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":62915,"kind":"person","name":"LAVU RATNAKAR","position":1,"cik":"0001737620","reported_name":"LAVU RATNAKAR","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Digital Info Ofr"}}],"security":"Common Stock","published_at":"2026-03-04T21:58:27.000Z","date":"2026-03-02","kind":"grant","planned":false,"acquired":true,"shares":6802,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents restricted share units. Restrictions lapse as follows: 3,401 shares each on 3/2/2027 and 3/2/2028."}],"balance_after":16371,"source":{"system":"sec-edgar","filing":"0001737620-26-000002","document":"wk-form4_1772661505.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000173762026000002/wk-form4_1772661505.xml","form_type":"4"}},{"id":862559,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":62915,"kind":"person","name":"LAVU RATNAKAR","position":1,"cik":"0001737620","reported_name":"LAVU RATNAKAR","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Digital Info Ofr"}}],"security":"Common Stock","published_at":"2026-03-04T21:58:27.000Z","date":"2026-03-02","kind":"grant","planned":false,"acquired":true,"shares":5101,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents restricted share units. Restrictions lapse as follows: 1,700 shares each on 3/2/2027 and 3/2/2028, and 1,701 on 3/2/2029."}],"balance_after":9569,"source":{"system":"sec-edgar","filing":"0001737620-26-000002","document":"wk-form4_1772661505.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000173762026000002/wk-form4_1772661505.xml","form_type":"4"}},{"id":862558,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":62915,"kind":"person","name":"LAVU RATNAKAR","position":1,"cik":"0001737620","reported_name":"LAVU RATNAKAR","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Digital Info Ofr"}}],"security":"Common Stock","published_at":"2026-03-04T21:58:27.000Z","date":"2026-03-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":315,"price":294.07,"value":92632.05,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK."}],"balance_after":4468,"source":{"system":"sec-edgar","filing":"0001737620-26-000002","document":"wk-form4_1772661505.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000173762026000002/wk-form4_1772661505.xml","form_type":"4"}},{"id":862557,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":62080,"kind":"person","name":"Kendrick Charles Morgan JR","position":1,"cik":"0001887908","reported_name":"Kendrick Charles Morgan JR","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & President, Commercial"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2026-03-04T21:58:09.000Z","date":"2026-03-02","kind":"grant","planned":false,"acquired":true,"shares":15870,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option represents a right to purchase a total of 15,870 shares, and is exercisable in three annual installments, each installment of 5,290 shares, beginning on 3/2/2027, which is the one-year anniversary of the option grant date."}],"balance_after":15870,"derivative":{"exercise_price":294.07,"expiration_date":"2036-03-02","underlying":"Common Stock","underlying_shares":15870},"source":{"system":"sec-edgar","filing":"0001887908-26-000002","document":"wk-form4_1772661487.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000188790826000002/wk-form4_1772661487.xml","form_type":"4"}},{"id":862556,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":62080,"kind":"person","name":"Kendrick Charles Morgan JR","position":1,"cik":"0001887908","reported_name":"Kendrick Charles Morgan JR","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & President, Commercial"}}],"security":"Common Stock","published_at":"2026-03-04T21:58:09.000Z","date":"2026-03-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":467,"price":284.03,"value":132642.01,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK."}],"balance_after":14987,"source":{"system":"sec-edgar","filing":"0001887908-26-000002","document":"wk-form4_1772661487.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000188790826000002/wk-form4_1772661487.xml","form_type":"4"}},{"id":862555,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":62080,"kind":"person","name":"Kendrick Charles Morgan JR","position":1,"cik":"0001887908","reported_name":"Kendrick Charles Morgan JR","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & President, Commercial"}}],"security":"Common Stock","published_at":"2026-03-04T21:58:09.000Z","date":"2026-03-02","kind":"grant","planned":false,"acquired":true,"shares":2532,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents performance based restricted share units. Restrictions lapsed on 3/2/2026."}],"balance_after":15454,"source":{"system":"sec-edgar","filing":"0001887908-26-000002","document":"wk-form4_1772661487.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000188790826000002/wk-form4_1772661487.xml","form_type":"4"}},{"id":862554,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":62080,"kind":"person","name":"Kendrick Charles Morgan JR","position":1,"cik":"0001887908","reported_name":"Kendrick Charles Morgan JR","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & President, Commercial"}}],"security":"Common Stock","published_at":"2026-03-04T21:58:09.000Z","date":"2026-03-02","kind":"grant","planned":false,"acquired":true,"shares":4017,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents restricted share units. Restrictions lapse as follows: 1,339 shares on 3/2/2027, 3/2/2028 and 3/2/2029."}],"balance_after":12922,"source":{"system":"sec-edgar","filing":"0001887908-26-000002","document":"wk-form4_1772661487.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000188790826000002/wk-form4_1772661487.xml","form_type":"4"}},{"id":862553,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":62080,"kind":"person","name":"Kendrick Charles Morgan JR","position":1,"cik":"0001887908","reported_name":"Kendrick Charles Morgan JR","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & President, Commercial"}}],"security":"Common Stock","published_at":"2026-03-04T21:58:09.000Z","date":"2026-03-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":1211,"price":294.07,"value":356118.77,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK."}],"balance_after":8905,"source":{"system":"sec-edgar","filing":"0001887908-26-000002","document":"wk-form4_1772661487.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000188790826000002/wk-form4_1772661487.xml","form_type":"4"}},{"id":862552,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":62914,"kind":"person","name":"Haytaian Peter D","position":1,"cik":"0001608538","reported_name":"Haytaian Peter D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Pres Carelon & CarelonRx"}}],"security":"Common Stock","published_at":"2026-03-04T21:57:53.000Z","date":"2026-03-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":446,"price":284.03,"value":126677.38,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK."}],"balance_after":27222,"source":{"system":"sec-edgar","filing":"0001608538-26-000002","document":"wk-form4_1772661470.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000160853826000002/wk-form4_1772661470.xml","form_type":"4"}},{"id":862551,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":62914,"kind":"person","name":"Haytaian Peter D","position":1,"cik":"0001608538","reported_name":"Haytaian Peter D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Pres Carelon & CarelonRx"}}],"security":"Common Stock","published_at":"2026-03-04T21:57:53.000Z","date":"2026-03-02","kind":"grant","planned":false,"acquired":true,"shares":2865,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents performance based restricted share units. Restrictions lapsed on 3/2/2026."}],"balance_after":27668,"source":{"system":"sec-edgar","filing":"0001608538-26-000002","document":"wk-form4_1772661470.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000160853826000002/wk-form4_1772661470.xml","form_type":"4"}},{"id":862550,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":62914,"kind":"person","name":"Haytaian Peter D","position":1,"cik":"0001608538","reported_name":"Haytaian Peter D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Pres Carelon & CarelonRx"}}],"security":"Common Stock","published_at":"2026-03-04T21:57:53.000Z","date":"2026-03-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":1201,"price":294.07,"value":353178.07,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK."}],"balance_after":24803,"source":{"system":"sec-edgar","filing":"0001608538-26-000002","document":"wk-form4_1772661470.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000160853826000002/wk-form4_1772661470.xml","form_type":"4"}},{"id":862549,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":42054,"kind":"person","name":"Kaye Mark","position":1,"cik":"0001748691","reported_name":"Kaye Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & CFO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2026-03-04T21:57:29.000Z","date":"2026-03-02","kind":"grant","planned":false,"acquired":true,"shares":25188,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option represents a right to purchase a total of 25,188 shares, and is exercisable in three annual installments, each installment of 8,396 shares, beginning on 3/2/2027, which is the one-year anniversary of the option grant date."}],"balance_after":25188,"derivative":{"exercise_price":294.07,"expiration_date":"2036-03-02","underlying":"Common Stock","underlying_shares":25188},"source":{"system":"sec-edgar","filing":"0001748691-26-000002","document":"wk-form4_1772661447.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000174869126000002/wk-form4_1772661447.xml","form_type":"4"}},{"id":862548,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":42054,"kind":"person","name":"Kaye Mark","position":1,"cik":"0001748691","reported_name":"Kaye Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & CFO"}}],"security":"Common Stock","published_at":"2026-03-04T21:57:29.000Z","date":"2026-03-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":353,"price":284.03,"value":100262.59,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK."}],"balance_after":32037,"source":{"system":"sec-edgar","filing":"0001748691-26-000002","document":"wk-form4_1772661447.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000174869126000002/wk-form4_1772661447.xml","form_type":"4"}},{"id":862547,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":42054,"kind":"person","name":"Kaye Mark","position":1,"cik":"0001748691","reported_name":"Kaye Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & CFO"}}],"security":"Common Stock","published_at":"2026-03-04T21:57:29.000Z","date":"2026-03-02","kind":"grant","planned":false,"acquired":true,"shares":10202,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents restricted share units. Restrictions lapse as follows: 5,101 shares each on 3/2/2027 and 3/2/2028."}],"balance_after":32390,"source":{"system":"sec-edgar","filing":"0001748691-26-000002","document":"wk-form4_1772661447.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000174869126000002/wk-form4_1772661447.xml","form_type":"4"}},{"id":862546,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":42054,"kind":"person","name":"Kaye Mark","position":1,"cik":"0001748691","reported_name":"Kaye Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & CFO"}}],"security":"Common Stock","published_at":"2026-03-04T21:57:29.000Z","date":"2026-03-02","kind":"grant","planned":false,"acquired":true,"shares":6377,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents restricted share units. Restrictions lapse as follows: 2,125 shares on 3/2/2027, and 2,126 shares each on 3/2/2028 and 3/2/2029."}],"balance_after":22188,"source":{"system":"sec-edgar","filing":"0001748691-26-000002","document":"wk-form4_1772661447.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000174869126000002/wk-form4_1772661447.xml","form_type":"4"}},{"id":862545,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":42054,"kind":"person","name":"Kaye Mark","position":1,"cik":"0001748691","reported_name":"Kaye Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & CFO"}}],"security":"Common Stock","published_at":"2026-03-04T21:57:29.000Z","date":"2026-03-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":271,"price":294.07,"value":79692.97,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK."}],"balance_after":15811,"source":{"system":"sec-edgar","filing":"0001748691-26-000002","document":"wk-form4_1772661447.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000174869126000002/wk-form4_1772661447.xml","form_type":"4"}},{"id":862544,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":12574,"kind":"person","name":"BOUDREAUX GAIL","position":1,"cik":"0001287920","reported_name":"BOUDREAUX GAIL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2026-03-04T21:56:45.000Z","date":"2026-03-02","kind":"grant","planned":false,"acquired":true,"shares":63818,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option represents a right to purchase a total of 63,818 shares, and is exercisable in three annual installments, with one installment of 21,272 shares and two installments of 21,273 shares each, beginning on 3/2/2027, which is the one-year anniversary of the option grant date."}],"balance_after":63818,"derivative":{"exercise_price":294.07,"expiration_date":"2036-03-02","underlying":"Common Stock","underlying_shares":63818},"source":{"system":"sec-edgar","filing":"0001287920-26-000002","document":"wk-form4_1772661402.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000128792026000002/wk-form4_1772661402.xml","form_type":"4"}},{"id":862543,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":12574,"kind":"person","name":"BOUDREAUX GAIL","position":1,"cik":"0001287920","reported_name":"BOUDREAUX GAIL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-03-04T21:56:45.000Z","date":"2026-03-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":1736,"price":284.03,"value":493076.08,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK."}],"balance_after":169251,"source":{"system":"sec-edgar","filing":"0001287920-26-000002","document":"wk-form4_1772661402.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000128792026000002/wk-form4_1772661402.xml","form_type":"4"}},{"id":862542,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":12574,"kind":"person","name":"BOUDREAUX GAIL","position":1,"cik":"0001287920","reported_name":"BOUDREAUX GAIL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-03-04T21:56:45.000Z","date":"2026-03-02","kind":"grant","planned":false,"acquired":true,"shares":10527,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents performance based restricted share units. Restrictions lapsed on 3/2/2026."}],"balance_after":170987,"source":{"system":"sec-edgar","filing":"0001287920-26-000002","document":"wk-form4_1772661402.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000128792026000002/wk-form4_1772661402.xml","form_type":"4"}},{"id":862541,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":12574,"kind":"person","name":"BOUDREAUX GAIL","position":1,"cik":"0001287920","reported_name":"BOUDREAUX GAIL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-03-04T21:56:45.000Z","date":"2026-03-02","kind":"grant","planned":false,"acquired":true,"shares":16153,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents restricted share units. Restrictions lapse as follows: 5,384 shares each on 3/2/2027 and 3/2/2028 and 5,385 shares on 3/2/2029."}],"balance_after":160460,"source":{"system":"sec-edgar","filing":"0001287920-26-000002","document":"wk-form4_1772661402.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000128792026000002/wk-form4_1772661402.xml","form_type":"4"}},{"id":862540,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":12574,"kind":"person","name":"BOUDREAUX GAIL","position":1,"cik":"0001287920","reported_name":"BOUDREAUX GAIL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-03-04T21:56:45.000Z","date":"2026-03-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":6713,"price":294.07,"value":1974091.91,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK."}],"balance_after":144307,"source":{"system":"sec-edgar","filing":"0001287920-26-000002","document":"wk-form4_1772661402.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000128792026000002/wk-form4_1772661402.xml","form_type":"4"}},{"id":922486,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":16563,"kind":"person","name":"SCHULMAN AMY W","position":1,"cik":"0001438226","reported_name":"SCHULMAN AMY W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-02-03T21:42:37.000Z","date":"2026-02-02","kind":"grant","planned":false,"acquired":true,"shares":218,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Phantom Stock units accrued under the Elevance Health, Inc. (\"Company\") Board of Directors Compensation Program."},{"field":"shares","element":"transactionShares","label":"F2","text":"The phantom stock units shall be payable in Company common stock upon the first to occur of (a) five years from the date of the annual meeting of shareholders that immediately precedes the Director's election date or (b) the date the Reporting Person ceases to be a member of the Company's board of directors, unless a later date is designated in the Reporting Person's election made under the Company's Board of Directors Deferred Compensation Plan."}],"balance_after":218,"source":{"system":"sec-edgar","filing":"0001438226-26-000005","document":"wk-form4_1770154954.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000143822626000005/wk-form4_1770154954.xml","form_type":"4"}},{"id":922485,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":10030,"kind":"person","name":"Craig Ryan R","position":1,"cik":"0002084547","reported_name":"Craig Ryan R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief HR Officer"}}],"security":"Common Stock","published_at":"2026-02-03T21:15:20.000Z","date":"2026-02-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":279,"price":341.83,"value":95370.57,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK."}],"balance_after":4032,"source":{"system":"sec-edgar","filing":"0002084547-26-000003","document":"wk-form4_1770153318.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000208454726000003/wk-form4_1770153318.xml","form_type":"4"}},{"id":1025211,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":42054,"kind":"person","name":"Kaye Mark","position":1,"cik":"0001748691","reported_name":"Kaye Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & CFO"}}],"security":"Common Stock","published_at":"2025-10-03T20:17:15.000Z","date":"2025-10-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":2895,"price":340.24,"value":984994.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK."}],"balance_after":16082,"source":{"system":"sec-edgar","filing":"0001748691-25-000007","document":"wk-form4_1759522630.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000174869125000007/wk-form4_1759522630.xml","form_type":"4"}},{"id":1047022,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":10035,"kind":"person","name":"Wessling Erin M","position":1,"cik":"0002084548","reported_name":"Wessling Erin M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Legal Officer"}}],"security":"Common Stock","published_at":"2025-09-05T20:21:42.000Z","date":"2025-09-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":152,"price":321.59,"value":48881.68,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK."}],"balance_after":5020,"source":{"system":"sec-edgar","filing":"0002084548-25-000004","document":"wk-form4_1757103700.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000208454825000004/wk-form4_1757103700.xml","form_type":"4"}},{"id":1048293,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":10035,"kind":"person","name":"Wessling Erin M","position":1,"cik":"0002084548","reported_name":"Wessling Erin M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Legal Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-09-04T15:53:47.000Z","date":"2025-09-02","kind":"grant","planned":false,"acquired":true,"shares":3541,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option represents a right to purchase a total of 3,541 shares, and is exercisable in three annual installments, with two installments of 1,180 shares each and one installment of 1,181 shares, beginning on 9/2/2026, which is the one-year anniversary of the option grant date."}],"balance_after":3541,"derivative":{"exercise_price":322.33,"expiration_date":"2035-09-02","underlying":"Common Stock","underlying_shares":3541},"source":{"system":"sec-edgar","filing":"0002084548-25-000002","document":"wk-form4_1757001225.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000208454825000002/wk-form4_1757001225.xml","form_type":"4"}},{"id":1048292,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":10035,"kind":"person","name":"Wessling Erin M","position":1,"cik":"0002084548","reported_name":"Wessling Erin M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Legal Officer"}}],"security":"Common Stock","published_at":"2025-09-04T15:53:47.000Z","date":"2025-09-02","kind":"grant","planned":false,"acquired":true,"shares":931,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted share units. Restrictions lapse as follows: 310 shares each on 9/2/2026 and 9/2/2027, and 311 on 9/2/2028."}],"balance_after":5172,"source":{"system":"sec-edgar","filing":"0002084548-25-000002","document":"wk-form4_1757001225.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000208454825000002/wk-form4_1757001225.xml","form_type":"4"}},{"id":1048291,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":10030,"kind":"person","name":"Craig Ryan R","position":1,"cik":"0002084547","reported_name":"Craig Ryan R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief HR Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-09-04T15:53:06.000Z","date":"2025-09-02","kind":"grant","planned":false,"acquired":true,"shares":3690,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option represents a right to purchase a total of 3,690 shares, and is exercisable in three annual installments of 1,230 shares, beginning on 9/2/2026, which is the one-year anniversary of the option grant date."}],"balance_after":3690,"derivative":{"exercise_price":322.33,"expiration_date":"2035-09-02","underlying":"Common Stock","underlying_shares":3690},"source":{"system":"sec-edgar","filing":"0002084547-25-000002","document":"wk-form4_1757001184.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000208454725000002/wk-form4_1757001184.xml","form_type":"4"}},{"id":1048290,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":10030,"kind":"person","name":"Craig Ryan R","position":1,"cik":"0002084547","reported_name":"Craig Ryan R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief HR Officer"}}],"security":"Common Stock","published_at":"2025-09-04T15:53:06.000Z","date":"2025-09-02","kind":"grant","planned":false,"acquired":true,"shares":970,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted share units. Restrictions lapse as follows: 323 shares each on 9/2/2026 and 9/2/2027, and 324 shares on 9/2/2028."}],"balance_after":5353,"source":{"system":"sec-edgar","filing":"0002084547-25-000002","document":"wk-form4_1757001184.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000208454725000002/wk-form4_1757001184.xml","form_type":"4"}},{"id":1059491,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":43706,"kind":"person","name":"DeVore Susan D.","position":1,"cik":"0001587697","reported_name":"DeVore Susan D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-08-21T20:20:38.000Z","date":"2025-08-19","kind":"purchase","planned":false,"acquired":true,"shares":1200,"price":312.15,"value":374580.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple purchases at prices ranging from $312.06 to $312.19.  The price reported reflects the weighted average purchase price.  The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":3502,"source":{"system":"sec-edgar","filing":"0001587697-25-000007","document":"wk-form4_1755807634.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000158769725000007/wk-form4_1755807634.xml","form_type":"4"}},{"id":1075098,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":43542,"kind":"person","name":"COLLIS STEVEN H","position":1,"cik":"0001191508","reported_name":"COLLIS STEVEN H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-08-05T20:18:25.000Z","date":"2025-08-01","kind":"grant","planned":false,"acquired":true,"shares":639,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Phantom Stock units accrued under the Elevance Health, Inc. (\"Company\") Board of Directors Compensation Program."},{"field":"shares","element":"transactionShares","label":"F2","text":"The phantom stock units shall be payable in Company common stock upon the first to occur of (a) five years from the date of the annual meeting of shareholders that immediately precedes the Director's election date or (b) the date the Reporting Person ceases to be a member of the Company's board of directors, unless a later date is designated in the Reporting Person's election made under the Company's Board of Directors Deferred Compensation Plan."}],"balance_after":639,"source":{"system":"sec-edgar","filing":"0001156039-25-000124","document":"wk-form4_1754425101.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000115603925000124/wk-form4_1754425101.xml","form_type":"4"}},{"id":1084859,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":12574,"kind":"person","name":"BOUDREAUX GAIL","position":1,"cik":"0001287920","reported_name":"BOUDREAUX GAIL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-07-18T17:42:51.000Z","date":"2025-07-18","kind":"purchase","planned":false,"acquired":true,"shares":1050,"price":287.96,"value":302358.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple purchases at prices ranging from $287.72 to $288.14. The price reported reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":151020,"source":{"system":"sec-edgar","filing":"0001287920-25-000005","document":"wk-form4_1752860565.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000128792025000005/wk-form4_1752860565.xml","form_type":"4"}},{"id":1084858,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":12574,"kind":"person","name":"BOUDREAUX GAIL","position":1,"cik":"0001287920","reported_name":"BOUDREAUX GAIL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-07-18T17:42:51.000Z","date":"2025-07-18","kind":"purchase","planned":false,"acquired":true,"shares":5116,"price":287.12,"value":1468905.92,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple purchases at prices ranging from $286.70 to $287.69. The price reported reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":149970,"source":{"system":"sec-edgar","filing":"0001287920-25-000005","document":"wk-form4_1752860565.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000128792025000005/wk-form4_1752860565.xml","form_type":"4"}},{"id":1084857,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":12574,"kind":"person","name":"BOUDREAUX GAIL","position":1,"cik":"0001287920","reported_name":"BOUDREAUX GAIL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-07-18T17:42:51.000Z","date":"2025-07-18","kind":"purchase","planned":false,"acquired":true,"shares":2334,"price":286.07,"value":667687.38,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple purchases at prices ranging from $285.50 to $286.43. The price reported reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":144854,"source":{"system":"sec-edgar","filing":"0001287920-25-000005","document":"wk-form4_1752860565.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000128792025000005/wk-form4_1752860565.xml","form_type":"4"}},{"id":1145891,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":34539,"kind":"person","name":"STRABLE-SOETHOUT DEANNA D","position":1,"cik":"0001278726","reported_name":"STRABLE-SOETHOUT DEANNA D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-16T20:19:25.000Z","date":"2025-05-14","kind":"grant","planned":false,"acquired":true,"shares":601,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Deferred stock units accrued under the Elevance Health, Inc. (\"Company\") Board of Directors Compensation Program."},{"field":"shares","element":"transactionShares","label":"F2","text":"The deferred stock units shall be payable in Company common stock upon the first to occur of (a) five years from the date of grant or (b) the date the Reporting Person ceases to be a member of the Company's board of directors, unless a later date is designated in the Reporting Person's election made under the Company's Board of Directors Deferred Compensation Plan."}],"balance_after":1646,"source":{"system":"sec-edgar","filing":"0001156039-25-000092","document":"wk-form4_1747426756.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000115603925000092/wk-form4_1747426756.xml","form_type":"4"}},{"id":1145890,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":16329,"kind":"person","name":"Schneider Ryan M.","position":1,"cik":"0001420501","reported_name":"Schneider Ryan M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-16T20:18:55.000Z","date":"2025-05-14","kind":"grant","planned":false,"acquired":true,"shares":601,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Deferred stock units accrued under the Elevance Health, Inc. (\"Company\") Board of Directors Compensation Program."},{"field":"shares","element":"transactionShares","label":"F2","text":"The deferred stock units shall be payable in Company common stock upon the first to occur of (a) five years from the date of grant or (b) the date the Reporting Person ceases to be a member of the Company's board of directors, unless a later date is designated in the Reporting Person's election made under the Company's Board of Directors Deferred Compensation Plan."}],"balance_after":6600,"source":{"system":"sec-edgar","filing":"0001156039-25-000091","document":"wk-form4_1747426726.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000115603925000091/wk-form4_1747426726.xml","form_type":"4"}},{"id":1145889,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":17760,"kind":"person","name":"PERU RAMIRO G","position":1,"cik":"0001192045","reported_name":"PERU RAMIRO G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-16T20:18:24.000Z","date":"2025-05-14","kind":"grant","planned":false,"acquired":true,"shares":601,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Deferred stock units accrued under the Elevance Health, Inc. (\"Company\") Board of Directors Compensation Program."},{"field":"shares","element":"transactionShares","label":"F2","text":"The deferred stock units shall be payable in Company common stock upon the first to occur of (a) five years from the date of grant or (b) the date the Reporting Person ceases to be a member of the Company's board of directors, unless a later date is designated in the Reporting Person's election made under the Company's Board of Directors Deferred Compensation Plan."}],"balance_after":9345,"source":{"system":"sec-edgar","filing":"0001156039-25-000090","document":"wk-form4_1747426696.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000115603925000090/wk-form4_1747426696.xml","form_type":"4"}},{"id":1145888,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":47000,"kind":"person","name":"Neri Antonio F","position":1,"cik":"0001648401","reported_name":"Neri Antonio F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-16T20:17:57.000Z","date":"2025-05-14","kind":"grant","planned":false,"acquired":true,"shares":601,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Deferred stock units accrued under the Elevance Health, Inc. (\"Company\") Board of Directors Compensation Program."},{"field":"shares","element":"transactionShares","label":"F2","text":"The deferred stock units shall be payable in Company common stock upon the first to occur of (a) five years from the date of grant or (b) the date the Reporting Person ceases to be a member of the Company's board of directors, unless a later date is designated in the Reporting Person's election made under the Company's Board of Directors Deferred Compensation Plan."}],"balance_after":4925,"source":{"system":"sec-edgar","filing":"0001156039-25-000089","document":"wk-form4_1747426667.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000115603925000089/wk-form4_1747426667.xml","form_type":"4"}},{"id":1145887,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":46999,"kind":"person","name":"Jallal Bahija","position":1,"cik":"0001730038","reported_name":"Jallal Bahija","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-16T20:17:12.000Z","date":"2025-05-14","kind":"grant","planned":false,"acquired":true,"shares":601,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Deferred stock units accrued under the Elevance Health, Inc. (\"Company\") Board of Directors Compensation Program."},{"field":"shares","element":"transactionShares","label":"F2","text":"The deferred stock units shall be payable in Company common stock upon the first to occur of (a) five years from the date of grant or (b) the date the Reporting Person ceases to be a member of the Company's board of directors, unless a later date is designated in the Reporting Person's election made under the Company's Board of Directors Deferred Compensation Plan."}],"balance_after":4788,"source":{"system":"sec-edgar","filing":"0001156039-25-000088","document":"wk-form4_1747426626.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000115603925000088/wk-form4_1747426626.xml","form_type":"4"}},{"id":1145886,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":16069,"kind":"person","name":"HAY LEWIS III","position":1,"cik":"0001182705","reported_name":"HAY LEWIS III","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-16T20:16:32.000Z","date":"2025-05-14","kind":"grant","planned":false,"acquired":true,"shares":601,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Deferred stock units accrued under the Elevance Health, Inc. (\"Company\") Board of Directors Compensation Program."},{"field":"shares","element":"transactionShares","label":"F2","text":"The deferred stock units shall be payable in Company common stock upon the first to occur of (a) five years from the date of grant or (b) the date the Reporting Person ceases to be a member of the Company's board of directors, unless a later date is designated in the Reporting Person's election made under the Company's Board of Directors Deferred Compensation Plan."}],"balance_after":11507,"source":{"system":"sec-edgar","filing":"0001156039-25-000087","document":"wk-form4_1747426585.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000115603925000087/wk-form4_1747426585.xml","form_type":"4"}},{"id":1145885,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":36255,"kind":"person","name":"Dixon Robert L JR","position":1,"cik":"0001524849","reported_name":"Dixon Robert L JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-16T20:15:54.000Z","date":"2025-05-14","kind":"grant","planned":false,"acquired":true,"shares":601,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Deferred stock units accrued under the Elevance Health, Inc. (\"Company\") Board of Directors Compensation Program."},{"field":"shares","element":"transactionShares","label":"F2","text":"The deferred stock units shall be payable in Company common stock upon the first to occur of (a) five years from the date of grant or (b) the date the Reporting Person ceases to be a member of the Company's board of directors, unless a later date is designated in the Reporting Person's election made under the Company's Board of Directors Deferred Compensation Plan."}],"balance_after":10322,"source":{"system":"sec-edgar","filing":"0001156039-25-000086","document":"wk-form4_1747426546.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000115603925000086/wk-form4_1747426546.xml","form_type":"4"}},{"id":1145884,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":43706,"kind":"person","name":"DeVore Susan D.","position":1,"cik":"0001587697","reported_name":"DeVore Susan D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-16T20:15:15.000Z","date":"2025-05-14","kind":"grant","planned":false,"acquired":true,"shares":601,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Deferred stock units accrued under the Elevance Health, Inc. (\"Company\") Board of Directors Compensation Program."},{"field":"shares","element":"transactionShares","label":"F2","text":"The deferred stock units shall be payable in Company common stock upon the first to occur of (a) five years from the date of grant or (b) the date the Reporting Person ceases to be a member of the Company's board of directors, unless a later date is designated in the Reporting Person's election made under the Company's Board of Directors Deferred Compensation Plan."}],"balance_after":2302,"source":{"system":"sec-edgar","filing":"0001156039-25-000085","document":"wk-form4_1747426507.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000115603925000085/wk-form4_1747426507.xml","form_type":"4"}},{"id":1145883,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":13720,"kind":"person","name":"CLARK R KERRY","position":1,"cik":"0001180776","reported_name":"CLARK R KERRY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-16T20:14:19.000Z","date":"2025-05-14","kind":"grant","planned":false,"acquired":true,"shares":601,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Deferred stock units accrued under the Elevance Health, Inc. (\"Company\") Board of Directors Compensation Program."},{"field":"shares","element":"transactionShares","label":"F2","text":"The deferred stock units shall be payable in Company common stock upon the first to occur of (a) five years from the date of grant or (b) the date the Reporting Person ceases to be a member of the Company's board of directors, unless a later date is designated in the Reporting Person's election made under the Company's Board of Directors Deferred Compensation Plan."}],"balance_after":9640,"source":{"system":"sec-edgar","filing":"0001156039-25-000084","document":"wk-form4_1747426452.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000115603925000084/wk-form4_1747426452.xml","form_type":"4"}},{"id":1165853,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":42054,"kind":"person","name":"Kaye Mark","position":1,"cik":"0001748691","reported_name":"Kaye Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & CFO"}}],"security":"Common Stock","published_at":"2025-04-25T20:17:21.000Z","date":"2025-04-24","kind":"sale","planned":false,"acquired":false,"shares":4588,"price":424.82,"value":1949074.16,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades, each at the same price of $424.82."}],"balance_after":18977,"source":{"system":"sec-edgar","filing":"0001156039-25-000060","document":"wk-form4_1745612235.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000115603925000060/wk-form4_1745612235.xml","form_type":"4"}},{"id":1212939,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":38289,"kind":"person","name":"Penczek Ronald W","position":1,"cik":"0001659075","reported_name":"Penczek Ronald W","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CAO & Controller"}}],"security":"Common Stock","published_at":"2025-03-11T20:20:37.000Z","date":"2025-03-10","kind":"sale","planned":false,"acquired":false,"shares":443,"price":415.13,"value":183902.59,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades, each at the same price of $415.13."}],"balance_after":1847,"source":{"system":"sec-edgar","filing":"0001156039-25-000038","document":"wk-form4_1741724430.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000115603925000038/wk-form4_1741724430.xml","form_type":"4"}},{"id":1223470,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":62080,"kind":"person","name":"Kendrick Charles Morgan JR","position":1,"cik":"0001887908","reported_name":"Kendrick Charles Morgan JR","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & President, Commercial"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-03-05T22:52:53.000Z","date":"2025-03-03","kind":"grant","planned":false,"acquired":true,"shares":10828,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The option represents a right to purchase a total of 10,828 shares, and is exercisable in three annual installments, with two installments of 3,609 shares each and one installment of 3,610 shares, beginning on 3/3/2026, which is the one-year anniversary of the option grant date."}],"balance_after":10828,"derivative":{"exercise_price":395.5,"expiration_date":"2035-03-03","underlying":"Common Stock","underlying_shares":10828},"source":{"system":"sec-edgar","filing":"0001156039-25-000035","document":"wk-form4_1741215166.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000115603925000035/wk-form4_1741215166.xml","form_type":"4"}},{"id":1223469,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":62080,"kind":"person","name":"Kendrick Charles Morgan JR","position":1,"cik":"0001887908","reported_name":"Kendrick Charles Morgan JR","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & President, Commercial"}}],"security":"Common Stock","published_at":"2025-03-05T22:52:53.000Z","date":"2025-03-05","kind":"sale","planned":false,"acquired":false,"shares":3504,"price":396.3,"value":1388635.2,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades, each at the same price of $396.30."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"Balance includes 22.89 shares acquired on December 20, 2024 through a dividend reinvestment plan."}],"balance_after":10116,"source":{"system":"sec-edgar","filing":"0001156039-25-000035","document":"wk-form4_1741215166.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000115603925000035/wk-form4_1741215166.xml","form_type":"4"}},{"id":1223468,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":62080,"kind":"person","name":"Kendrick Charles Morgan JR","position":1,"cik":"0001887908","reported_name":"Kendrick Charles Morgan JR","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & President, Commercial"}}],"security":"Common Stock","published_at":"2025-03-05T22:52:53.000Z","date":"2025-03-03","kind":"grant","planned":false,"acquired":true,"shares":3686,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents performance based restricted share units. Restrictions lapse on 3/3/2025."}],"balance_after":13620,"source":{"system":"sec-edgar","filing":"0001156039-25-000035","document":"wk-form4_1741215166.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000115603925000035/wk-form4_1741215166.xml","form_type":"4"}},{"id":1223467,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":62080,"kind":"person","name":"Kendrick Charles Morgan JR","position":1,"cik":"0001887908","reported_name":"Kendrick Charles Morgan JR","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & President, Commercial"}}],"security":"Common Stock","published_at":"2025-03-05T22:52:53.000Z","date":"2025-03-03","kind":"grant","planned":false,"acquired":true,"shares":2845,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents restricted share units. Restrictions lapse as follows: 948 shares each on 3/3/2026 and 3/3/2027, and 949 shares on 3/3/2028."}],"balance_after":9934,"source":{"system":"sec-edgar","filing":"0001156039-25-000035","document":"wk-form4_1741215166.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000115603925000035/wk-form4_1741215166.xml","form_type":"4"}},{"id":1223466,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":62080,"kind":"person","name":"Kendrick Charles Morgan JR","position":1,"cik":"0001887908","reported_name":"Kendrick Charles Morgan JR","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & President, Commercial"}}],"security":"Common Stock","published_at":"2025-03-05T22:52:53.000Z","date":"2025-03-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":2221,"price":395.5,"value":878405.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK."}],"balance_after":7089,"source":{"system":"sec-edgar","filing":"0001156039-25-000035","document":"wk-form4_1741215166.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000115603925000035/wk-form4_1741215166.xml","form_type":"4"}},{"id":1223465,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":38289,"kind":"person","name":"Penczek Ronald W","position":1,"cik":"0001659075","reported_name":"Penczek Ronald W","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CAO & Controller"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-03-05T21:57:33.000Z","date":"2025-03-03","kind":"grant","planned":false,"acquired":true,"shares":1081,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option represents a right to purchase a total of 1,081 shares, and is exercisable in three annual installments, with two installments of 360 shares each and one installment of 361 shares, beginning on 3/3/2026, which is the one-year anniversary of the option grant date."}],"balance_after":1081,"derivative":{"exercise_price":395.5,"expiration_date":"2035-03-03","underlying":"Common Stock","underlying_shares":1081},"source":{"system":"sec-edgar","filing":"0001156039-25-000032","document":"wk-form4_1741211844.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000115603925000032/wk-form4_1741211844.xml","form_type":"4"}},{"id":1223464,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":38289,"kind":"person","name":"Penczek Ronald W","position":1,"cik":"0001659075","reported_name":"Penczek Ronald W","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CAO & Controller"}}],"security":"Common Stock","published_at":"2025-03-05T21:57:33.000Z","date":"2025-03-03","kind":"grant","planned":false,"acquired":true,"shares":421,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents performance based restricted share units. Restrictions lapse on 3/3/2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Balance includes 4.18 shares acquired on March 22, 2024, 3.99 shares acquired on June 25, 2024, 4.07 shares acquired on September 25, 2024 and 5.95 shares acquired on December 20, 2024 through a dividend reinvestment plan."}],"balance_after":2290,"source":{"system":"sec-edgar","filing":"0001156039-25-000032","document":"wk-form4_1741211844.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000115603925000032/wk-form4_1741211844.xml","form_type":"4"}}],"next_cursor":"2025-03-05T21:57:33.000000Z,1223464"}